Skip to content
10-Q

Quarterly Report

ENTERA BIO LTD. ENTX

0001178913-26-002458

← back to feed
Filed
May 8, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 4, 2026 49.23M sh
Shares Diluted Q1 2026 · Mar 31, 2026 47.76M sh
Shares Diluted Q1 2026 · Mar 31, 2025 43.38M sh
Capex Q1 2026 · Mar 31, 2026 $0
Capex Q1 2026 · Mar 31, 2025 $8K
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$3.09M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$1.4M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $4.14M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $7.11M
Cash And Equivalents Q1 2026 · Mar 31, 2025 $12.57M
Stockholders Equity Q1 2026 · Mar 31, 2026 $10.69M
Stockholders Equity Q1 2026 · Dec 31, 2025 $13.1M
Stockholders Equity Q1 2026 · Mar 31, 2025 $19.38M
Stockholders Equity Q1 2026 · Dec 31, 2024 $8.08M
Current Liabilities Q1 2026 · Mar 31, 2026 $1.58M
Current Liabilities Q1 2026 · Dec 31, 2025 $2.2M
Total Liabilities Q1 2026 · Mar 31, 2026 $2.44M
Total Liabilities Q1 2026 · Dec 31, 2025 $2.89M
Current Assets Q1 2026 · Mar 31, 2026 $12.49M
Current Assets Q1 2026 · Dec 31, 2025 $15.3M
Total Assets Q1 2026 · Mar 31, 2026 $13.13M
Total Assets Q1 2026 · Dec 31, 2025 $15.99M
Eps Diluted Q1 2026 · Mar 31, 2026 $0.07
Eps Diluted Q1 2026 · Mar 31, 2025 $0.06
Eps Basic Q1 2026 · Mar 31, 2026 $0.07
Eps Basic Q1 2026 · Mar 31, 2025 $0.06
Sga Expense Q1 2026 · Mar 31, 2026 $128K
Sga Expense Q1 2026 · Mar 31, 2025 $123K
Rd Expense Q1 2026 · Mar 31, 2026 $2.25M
Rd Expense Q1 2026 · Mar 31, 2025 $1.12M
Net Income Q1 2026 · Mar 31, 2026 −$3.51M
Net Income Q1 2026 · Mar 31, 2025 −$2.57M
Operating Income Q1 2026 · Mar 31, 2026 −$3.54M
Operating Income Q1 2026 · Mar 31, 2025 −$2.56M
Gross Profit Q1 2026 · Mar 31, 2026 $0
Gross Profit Q1 2026 · Mar 31, 2025 $0
Cost Of Revenue Q1 2026 · Mar 31, 2026 $0
Cost Of Revenue Q1 2026 · Mar 31, 2025 $42K
Revenue Q1 2026 · Mar 31, 2026 $0
Revenue Q1 2026 · Mar 31, 2025 $42K